Strides Arcolab received a nod by the US FDA for an Oncology unit in Bengaluru. Arun Kumar, group CEO and vice chairman of Strides Arcolab, in an exclusive interview with CNBC-TV18 shares that the company expects approvals on approximately USD 4-5 billon product filings in the next few weeks.
first published: May 2, 2011 12:58 pm
A collection of the most-viewed Moneycontrol videos.
Live: Can Nifty hold 26,000 as Q3 updates trickle in? | Opening Bell
Live: Nifty extends fall to the 3rd day, breaks below 26,100 | Closing Bell
Live: Can Nifty hold 26,200, break 2-day dull performance? | Opening Bell
Live: Nifty breaks below 26,200 on expiry day, broader markets underperform | Closing Bell
